|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miyauchi T, Masuzawa Y and Muramatsu T:
The basigin group of the immunoglobulin superfamily: Complete
conservation of a segment in and around transmembrane domains of
human and mouse basigin and chicken HT7 antigen. J Biochem.
110:770–774. 1991.PubMed/NCBI
|
|
3
|
Yan L, Zucker S and Toole BP: Roles of the
multifunctional glycoprotein, emmprin (basigin; CD147), in tumour
progression. Thromb Haemost. 93:199–204. 2005.PubMed/NCBI
|
|
4
|
Zou W, Yang H, Hou X, Zhang W, Chen B and
Xin X: Inhibition of CD147 gene expression via RNA interference
reduces tumor cell invasion, tumorigenicity and increases
chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett.
248:211–218. 2007. View Article : Google Scholar
|
|
5
|
Liang L, Major T and Bocan T:
Characterization of the promoter of human extracellular matrix
metalloproteinase inducer (EMMPRIN). Gene. 282:75–86. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kong LM, Liao Cg, Chen L, Yang HS, Zhang
SH, Zhang Z, Bian HJ, Xing JL and Chen ZN: Promoter hypomethylation
up-regulates CD147 expression through increasing Sp1 binding and
associates with poor prognosis in human hepatocellular carcinoma. J
Cell Mol Med. 15:1415–1428. 2011. View Article : Google Scholar
|
|
7
|
Chu S: Transcriptional regulation by
post-transcriptional modification – role of phosphorylation in Sp1
transcriptional activity. Gene. 508:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kong LM, Liao CG, Fei F, Guo X, Xing JL
and Chen ZN: Transcription factor Sp1 regulates expression of
cancer-associated molecule CD147 in human lung cancer. Cancer Sci.
101:1463–1470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng XL, Matsubara S, Diao C, Hollenberg
MD and Wong NC: Epidermal growth factor induction of apolipoprotein
A-I is mediated by the Ras-MAP kinase cascade and Sp1. J Biol Chem.
276:13822–13829. 2001.PubMed/NCBI
|
|
10
|
Tan NY, Midgley VC, Kavurma MM, Santiago
FS, Luo X, Peden R, Fahmy RG, Berndt MC, Molloy MP and Khachigian
LM: Angiotensin II-inducible platelet-derived growth factor-D
transcription requires specific Ser/Thr residues in the second zinc
finger region of Sp1. Circ Res. 102:e38–e51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsu MC, Chang HC and Hung WC: HER-2/neu
represses the metastasis suppressor RECK via ERK and Sp
transcription factors to promote cell invasion. J Biol Chem.
281:4718–4725. 2006. View Article : Google Scholar
|
|
12
|
Wei S, Chuang HC, Tsai WC, Yang HC, Ho SR,
Paterson AJ, Kulp SK and Chen CS: Thiazolidinediones mimic glucose
starvation in facilitating Sp1 degradation through the
up-regulation of beta-transducin repeat-containing protein. Mol
Pharmacol. 76:47–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Q, Li J, Xing J, Li W, Li H, Ke X,
Zhang J, Ren T, Shang Y, Yang H, et al: CD147 promotes
reprogramming of glucose metabolism and cell proliferation in HCC
cells by inhibiting the p53-dependent signaling pathway. J Hepatol.
61:859–866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Pan Y, Gu L, Nie Z, He B, Song G,
Li R, Xu Y, Gao T and Wang S: ERK1/2 signalling pathway is involved
in CD147-mediated gastric cancer cell line SGC7901 proliferation
and invasion. Exp Biol Med. 238:903–912. 2013. View Article : Google Scholar
|
|
15
|
Khunkeawla P, Moonsom S, Staffler G,
Kongtawelert P and Kasinrerk W: Engagement of CD147
molecule-induced cell aggregation through the activation of protein
kinases and reorganization of the cytoskeleton. Immunobiology.
203:659–669. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Xu J, Chen L, Zhong WD, Zhang Z, Mi
L, Zhang Y, Liao CG, Bian HJ, Jiang JL, et al: HAb18g (CD147), a
cancer-associated biomarker and its role in cancer detection.
Histopathology. 54:677–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao SH, Wang Y, Wen L, Zhai ZB, Ai ZH,
Yao NL, Wang L, Liu WC, Chen BL, Li Y, et al: Basigin-2 is the
predominant basigin isoform that promotes tumor cell migration and
invasion and correlates with poor prognosis in epithelial ovarian
cancer. J Transl Med. 11:922013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanekura T, Chen X and Kanzaki T: Basigin
(CD147) is expressed on melanoma cells and induces tumor cell
invasion by stimulating production of matrix metalloproteinases by
fibroblasts. Int J Cancer. 99:520–528. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ru NY, Wu J, Chen ZN and Bian H:
Hab18g/cd147 is involved in TGF-β-induced epithelial-mesenchymal
transition and hepatocellular carcinoma invasion. Cell Biol Int.
39:44–51. 2015. View Article : Google Scholar
|
|
20
|
Kong LM, Liao CG, Zhang Y, Xu J, Li Y,
Huang W, Zhang Y, Bian H and Chen ZN: A regulatory loop involving
miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer
invasion and metastasis. Cancer Res. 74:3764–3778. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chu D, Zhu S, Li J, Ji G, Wang W, Wu G and
Zheng J: CD147 Expression in human gastric cancer is associated
with tumor recurrence and prognosis. PLoS One. 9:e1010272014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao J, Hu Z, Liu J, Liu D, Wang Y, Cai M,
Zhang D, Tan M and Lin B: Expression of CD147 and Lewis y antigen
in ovarian cancer and their relationship to drug resistance. Med
Oncol. 31:9202014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu J, Xu HY, Zhang Q, Song F, Jiang JL,
Yang XM, Mi L, Wen N, Tian R, Wang L, et al: HAb18G/CD147 functions
in invasion and metastasis of hepatocellular carcinoma. Mol Cancer
Res. 5:605–614. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Shang P, Qian AR, Wang L, Yang Y and
Chen ZN: Inhibitory effects of antisense RNA of HAb18G/CD147 on
invasion of hepatocellular carcinoma cells in vitro. World J
gastroenterol. 9:2174–2177. 2003.PubMed/NCBI
|
|
25
|
Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN
and Chan HC: The involvement of HAb18G/CD147 in regulation of
store-operated calcium entry and metastasis of human hepatoma
cells. J Biol Chem. 276:46870–46877. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Briggs MR, Kadonaga JT, Bell SP and Tjian
R: Purification and biochemical characterization of the
promoter-specific transcription factor, Sp1. Science. 234:47–52.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kadonaga JT, Carner KR, Masiarz FR and
Tjian R: Isolation of cDNA encoding transcription factor Sp1 and
functional analysis of the DNA binding domain. Cell. 51:1079–1090.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kadonaga JT and Tjian R: Affinity
purification of sequence-specific DNA binding proteins. Proc Natl
Acad Sci USA. 83:5889–5893. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Näär AM, Ryu S and Tjian R: Cofactor
requirements for transcriptional activation by Sp1. Cold Spring
Harb Symp Quant Biol. 63:189–199. 1998. View Article : Google Scholar
|
|
30
|
Parisi F, Wirapati P and Naef F:
Identifying synergistic regulation involving c-Myc and sp1 in human
tissues. Nucleic Acids Res. 35:1098–1107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McDonough PM, Hanford DS, Sprenkle AB,
Mellon NR and Glembotski CC: Collaborative roles for c-Jun
N-terminal kinase, c-Jun, serum response factor, and Sp1 in
calcium-regulated myocardial gene expression. J Biol Chem.
272:24046–24053. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Canaff L, Zhou X and Hendy GN: The
proinflammatory cytokine, interleukin-6, up-regulates
calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3.
J Biol Chem. 283:13586–13600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brunn GJ, Williams J, Sabers C,
Wiederrecht G, Lawrence JC Jr and Abraham RT: Direct inhibition of
the signaling functions of the mammalian target of rapamycin by the
phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO
J. 15:5256–5267. 1996.PubMed/NCBI
|
|
34
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fruman DA and Rommel C: PI3K and cancer:
Lessons, challenges and opportunities. Nat Rev Drug Discov.
13:140–156. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boulton TG, Nye SH, Robbins DJ, Ip NY,
Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH
and Yancopoulos GD: ERKs: A family of protein-serine/threonine
kinases that are activated and tyrosine phosphorylated in response
to insulin and NGF. Cell. 65:663–675. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Boulton TG, Yancopoulos GD, Gregory JS,
Slaughter C, Moomaw C, Hsu J and Cobb MH: An insulin-stimulated
protein kinase similar to yeast kinases involved in cell cycle
control. Science. 249:64–67. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meloche S and Pouysségur J: The ERK1/2
mitogen-activated protein kinase pathway as a master regulator of
the G1- to S-phase transition. Oncogene. 26:3227–3239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gille H, Kortenjann M, Thomae O, Moomaw C,
Slaughter C, Cobb MH and Shaw PE: ERK phosphorylation potentiates
Elk-1-mediated ternary complex formation and transactivation. EMBO
J. 14:951–962. 1995.PubMed/NCBI
|
|
40
|
Murphy LO, Smith S, Chen RH, Fingar DC and
Blenis J: Molecular interpretation of ERK signal duration by
immediate early gene products. Nat Cell Biol. 4:556–564.
2002.PubMed/NCBI
|
|
41
|
Whitmarsh AJ and Davis RJ: Transcription
factor AP-1 regulation by mitogen-activated protein kinase signal
transduction pathways. J Mol Med Berl. 74:589–607. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Alessi DR, Cuenda A, Cohen P, Dudley DT
and Saltiel AR: PD 098059 is a specific inhibitor of the activation
of mitogen-activated protein kinase kinase in vitro and in vivo. J
Biol Chem. 270:27489–27494. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dudley DT, Pang L, Decker SJ, Bridges AJ
and Saltiel AR: A synthetic inhibitor of the mitogen-activated
protein kinase cascade. Proc Natl Acad Sci USA. 92:7686–7689. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yao JC, Wang L, Wei D, Gong W, Hassan M,
Wu TT, Mansfield P, Ajani J and Xie K: Association between
expression of transcription factor Sp1 and increased vascular
endothelial growth factor expression, advanced stage, and poor
survival in patients with resected gastric cancer. Clin Cancer Res.
10:4109–4117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Frémin C and Meloche S: From basic
research to clinical development of MEK1/2 inhibitors for cancer
therapy. J Hematol Oncol. 3:82010. View Article : Google Scholar : PubMed/NCBI
|
